SBIR TOPIC 266: NANOPARTICLE ENABLED SINGLE CELL MASS SPECTROMETRY FOR RARE CELL

Information

  • Research Project
  • 7952367
  • ApplicationId
    7952367
  • Core Project Number
    261200900050C-0-0-1
  • Full Project Number
    261200900050C-0-0-1
  • Serial Number
    0
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/2009 - 16 years ago
  • Project End Date
    3/30/2010 - 15 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2009
  • Support Year
  • Suffix
  • Award Notice Date
    -
Organizations

SBIR TOPIC 266: NANOPARTICLE ENABLED SINGLE CELL MASS SPECTROMETRY FOR RARE CELL

The goal of the Phase I research period is to develop a prototype technique for the rapid MALDI mass spectral analysis of individual mammalian cells. All of the components necessary to achieve this goal have been demonstrated independently. Gold nanoparticles developed at nanoComposix have demonstrated high sensitivity for MALDI-MS applications with little background interference in the low m/z spectral region. Flow cytometry and cell sorting technology has been developed and used over the last 30 years. Aerosol time-of-flight mass spectrometry has been used for complex bioaerosol characterization for close to 10 years. The innovation behind the proposed research is combining the use of all three techniques to build a high throughput single cell MALDI mass spectrometer. During the Phase I research, nanoComposix will fabricate and characterize a series of AuNPs that will be used as a high sensitivity, low background MALDI matrix for the analysis of small MW biomolecules from individual aerosolized mammalian cells. Proof of concept experiments using in-vitro mammalian cell systems will be used to test differences in MALDI mass spectra associated with different nanoparticle application strategies and aerosol generation parameters. Instrumentation that generates the aerosol will be coupled to the ATOFMS and optimized AuNP matrix/cell formulations will be analyzed in an on-line format.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    N43
  • Administering IC
    CA
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    199981
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:199981\
  • Funding Mechanism
    Contracts, Extramural
  • Study Section
  • Study Section Name
  • Organization Name
    NANOCOMPOSIX, INC.
  • Organization Department
  • Organization DUNS
    159070825
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92111
  • Organization District
    UNITED STATES